Relationship between genotype and phenotype in monogenic diseases: Relevance to polygenic diseases
暂无分享,去创建一个
[1] B. Kerem,et al. Genotype‐phenotype correlations in cystic fibrosis , 1996, Pediatric pulmonology.
[2] J. Witte,et al. Genetic dissection of complex traits. , 1994, Nature genetics.
[3] G. Lathrop,et al. Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach , 1996, Nature Genetics.
[4] L. Tsui,et al. Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia , 1995, The Lancet.
[5] Arthur M Buchberg,et al. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin -induced intestinal neoplasia , 1995, Cell.
[6] S. Orkin,et al. Lethal β-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF , 1995, Nature.
[7] F. Grosveld,et al. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene , 1995, Nature.
[8] R. Kelley,et al. Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of cholesterol precursors in amniotic fluid. , 1995, American journal of medical genetics.
[9] P. Gros,et al. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. , 1995, American journal of human genetics.
[10] M. Faerman,et al. Sequence analysis reveals a β–thalassaemia mutation in the DNA of skeletal remains from the archaeological site of Akhziv, Israel , 1995, Nature Genetics.
[11] G. Velho,et al. A missense mutation in the glucagon receptor gene is associated with non–insulin–dependent diabetes mellitus , 1995, Nature Genetics.
[12] W. Rutter,et al. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription , 1995, Nature Genetics.
[13] J. Todd,et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus , 1995, Nature Genetics.
[14] G. Novelli,et al. Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. , 1995, American journal of human genetics.
[15] A. Chapelle,et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability , 1995, Nature Genetics.
[16] P. Modrich,et al. Mismatch repair, genetic stability, and cancer. , 1994, Science.
[17] R. Fleischmann,et al. Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.
[18] H. Dietz,et al. A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. , 1994, The New England journal of medicine.
[19] B. Kerem,et al. Correlation between genotype and phenotype in patients with cystic fibrosis. , 1994, The New England journal of medicine.
[20] A. Cao. 1993 William Allan award address. , 1994, American journal of human genetics.
[21] G. Lathrop,et al. Detection of a major gene for heterocellular hereditary persistence of fetal hemoglobin after accounting for genetic modifiers. , 1994, American journal of human genetics.
[22] C. P. Morris,et al. Mutation analysis of 28 Gaucher disease patients: the Australasian experience. , 1994, American journal of medical genetics.
[23] J. Amos,et al. The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. , 1994, Journal of andrology.
[24] E. Lander,et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse , 1993, Cell.
[25] M. Gentile,et al. Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP) , 1993, American journal of human genetics.
[26] L. Tsui,et al. A mutation in CFTR produces different phenotypes depending on chromosomal background , 1993, Nature Genetics.
[27] A. Lindblom,et al. Genetic mapping of a second locus predisposing to hereditary non–polyposis colon cancer , 1993, Nature Genetics.
[28] S. Milstien,et al. Mutation in the 4a-carbinolamine dehydratase gene leads to mild hyperphenylalaninemia with defective cofactor metabolism. , 1993, American journal of human genetics.
[29] Riccardi Vm. Genotype, malleotype, phenotype, and randomness: lessons from neurofibromatosis-1 (NF-1) , 1993 .
[30] E. Nieschlag,et al. Compound heterozygosity for the delta F508 and F508C cystic fibrosis transmembrane conductance regulator (CFTR) mutations in a patient with congenital bilateral aplasia of the vas deferens. , 1993, American journal of human genetics.
[31] C. Eng,et al. Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications. , 1993, American journal of human genetics.
[32] J. Weber,et al. Genetic mapping of a locus predisposing to human colorectal cancer. , 1993, Science.
[33] S N Thibodeau,et al. Microsatellite instability in cancer of the proximal colon. , 1993, Science.
[34] K. Kinzler,et al. Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.
[35] S. Forrest,et al. Comparison of genotype and intellectual phenotype in untreated PKU patients. , 1993, Journal of medical genetics.
[36] Johanna M. Rommens,et al. The cystic fibrosis mutation (ΔF508) does not influence the chloride channel activity of CFTR , 1993, Nature Genetics.
[37] J. Beckmann,et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. , 1993, The New England journal of medicine.
[38] M. Robertson,et al. Identification of APC gene mutations in Italian adenomatous polyposis coli patients by PCR-SSCP analysis. , 1993, American journal of human genetics.
[39] B. Tümmler,et al. Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis , 1993, The Lancet.
[40] C. Boeck. Correlation between genotype and phenotype in patients with cystic fibrosis , 1993 .
[41] D. Cox,et al. DNA markers for the diagnosis of Wilson disease. , 1993, Journal of hepatology.
[42] M. Macek,et al. Missense variations in the cystic fibrosis gene: heteroduplex formation in the F508C mutation. , 1992, American journal of human genetics.
[43] T. Kurtz,et al. Gene mapping in experimental hypertension. , 1992, Journal of the American Society of Nephrology : JASN.
[44] L. Abel,et al. Segregation analysis detects a major gene controlling blood infection levels in human malaria. , 1992, American journal of human genetics.
[45] M. Corey,et al. Genetic determination of exocrine pancreatic function in cystic fibrosis. , 1992, American journal of human genetics.
[46] K. Kinzler,et al. Erratum: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.
[47] J. Chalk,et al. Spasticity and white matter abnormalities in adult phenylketonuria. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[48] M. Stoffel,et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.
[49] M. White,et al. Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. , 1992 .
[50] J. Gordon,et al. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system , 1992, The Journal of cell biology.
[51] S. Woo,et al. Molecular basis of phenylketonuria and related hyperphenylalaninemias: Mutations and polymorphisms in the human phenylalanine hydroxylase gene , 1992, Human mutation.
[52] T. Dörk,et al. A cystic fibrosis allele encoding missense mutations in both nucleotide binding folds of the cystic fibrosis transmembrane conductance regulator , 1992, Human mutation.
[53] T. Smyrk,et al. Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. , 1992, American journal of human genetics.
[54] R. Williams. Key concepts regarding the genetics of hypertension in humans. , 1991, American journal of hypertension.
[55] K. Kinzler,et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.
[56] J. McPherson,et al. Identification of deletion mutations and three new genes at the familial polyposis locus , 1991, Cell.
[57] S. Altschul,et al. Identification of FAP locus genes from chromosome 5q21. , 1991, Science.
[58] Y. Shiloh,et al. Compound heterozygosity in nonphenylketonuria hyperphenylalanemia: the contribution of mutations for classical phenylketonuria. , 1991, American journal of human genetics.
[59] F. Güttler,et al. Molecular basis of phenotypic heterogeneity in phenylketonuria. , 1991, The New England journal of medicine.
[60] R. Elston,et al. Use of the robust sib-pair method to screen for single-locus, multiple-locus, and pleiotropic effects: application to traits related to hypertension. , 1991, American journal of human genetics.
[61] J. Groffen,et al. Different clinical manifestations of hyperphenylalaninemia in three siblings with identical phenylalanine hydroxylase genes. , 1991, American journal of human genetics.
[62] J. Boué,et al. The ΔF508 mutation in mild adult forms of cystic fibrosis (CF) , 1991 .
[63] D Markiewicz,et al. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). , 1990, The New England journal of medicine.
[64] M. Hodson,et al. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis , 1990, The Lancet.
[65] A. Beaudet,et al. Benign missense variations in the cystic fibrosis gene. , 1990, American journal of human genetics.
[66] Philippe Roussel,et al. Abnormal distribution of CF ΔF508 allele in azoospermic men with congenital aplasia of epididymis and vas deferens , 1990, The Lancet.
[67] R. Rozen,et al. Recurrent mutation, gene conversion, or recombination at the human phenylalanine hydroxylase locus: evidence in French-Canadians and a catalog of mutations. , 1990, American journal of human genetics.
[68] D. Malo,et al. Immunogenetics of mycobacterial infections: mouse-human homologies. , 1990, The Journal of infectious diseases.
[69] J M Lalouel,et al. Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. , 1990, The New England journal of medicine.
[70] K. Aalto-Setälä,et al. Molecular genetics of hypercholesterolemia. , 1990, Annals of medicine.
[71] H. Pitot,et al. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.
[72] S C Hunt,et al. Current knowledge regarding the genetics of human hypertension. , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[73] L. Tsui,et al. Erratum: Identification of the Cystic Fibrosis Gene: Genetic Analysis , 1989, Science.
[74] L. Tsui,et al. Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.
[75] M. Corey,et al. Familial concordance of pancreatic function in cystic fibrosis. , 1989, The Journal of pediatrics.
[76] A. Schechter,et al. Intracellular Polymerization , 1989, Annals of the New York Academy of Sciences.
[77] G. Saglio,et al. A benign form of thalassaemia intermedia may be determined by the interaction of triplicated α locus and heterozygous β‐thalassaemia , 1987 .
[78] J. Wainscoat,et al. Thalassaemia intermedia: interaction of the triple α‐globin gene arrangement and heterozygous β‐thalassaemia , 1987 .
[79] F. Ledley,et al. Molecular analysis of the inheritance of phenylketonuria and mild hyperphenylalaninemia in families with both disorders. , 1986, The New England journal of medicine.
[80] A. Hoffbrand,et al. Thalassaemia intermedia: a new molecular basis , 1984, British journal of haematology.
[81] W. Wood,et al. The triplicated α gene locus and β thalassaemia , 1983 .
[82] E. Kanavakis,et al. The triplicated alpha gene locus and beta thalassaemia. , 1983, British journal of haematology.
[83] A. Cao,et al. Alpha globin gene analysis in a Sardinian family with interacting alpha and beta thalassaemia genes , 1983, British journal of haematology.
[84] J. Clegg,et al. Thalassaemia intermedia in Cyprus: the interaction of alpha and beta thalassaemia. , 1983 .
[85] J. Clegg,et al. Thalassaemia intermedia in Cyprus: the interaction of α and β thalassaemia , 1983, British journal of haematology.
[86] D. Weatherall,et al. The interaction of α thalassaemia with heterozygous β thalassaemia , 1982, British journal of haematology.
[87] Julian R. E. Davis,et al. Concurrent Sickle-Cell Anemia and α-Thalassemia: Effect on Severity of Anemia , 1982 .
[88] A. Schechter,et al. What determines severity in sickle-cell disease? , 1982, The New England journal of medicine.
[89] P. Gros,et al. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. , 1981, Journal of immunology.
[90] M. Cappellini,et al. Interaction between Homozygous β0 Thalassaemia and the Swiss Type of Hereditary Persistence of Fetal Haemoglobin , 1981, British journal of haematology.
[91] V. McKusick,et al. The Marfan syndrome: diagnosis and management. , 1979, The New England journal of medicine.
[92] T. Necheles,et al. Mild sickle cell disease. Clinical and laboratory studies. , 1973, JAMA.
[93] H. Ranney. Interactions of other hemoglobin variants with sickle-cell hemoglobin. , 1970, The New England journal of medicine.